These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15655384)

  • 1. Commentary: The ALLHAT Study: implications for the management of resistant hypertension.
    Singer GM; Setaro JF
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):31-2. PubMed ID: 15655384
    [No Abstract]   [Full Text] [Related]  

  • 2. The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):485-7. PubMed ID: 12797357
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
    Oparil S
    Hypertension; 2003 May; 41(5):1006-9. PubMed ID: 12695423
    [No Abstract]   [Full Text] [Related]  

  • 4. ALLHAT and beyond.
    Alderman MH
    Am J Hypertens; 2003 Jun; 16(6):512-4. PubMed ID: 12799104
    [No Abstract]   [Full Text] [Related]  

  • 5. ALLHAT: setting the record straight.
    Davis BR; Furberg CD; Wright JT; Cutler JA; Whelton P;
    Ann Intern Med; 2004 Jul; 141(1):39-46. PubMed ID: 15238369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on the renal aspects of the ALLHAT study.
    Ruilope LM
    J Hypertens; 2003 Feb; 21(2):235-6. PubMed ID: 12569244
    [No Abstract]   [Full Text] [Related]  

  • 7. Never mind the quality, feel the width--ALLHAT revisited.
    McInnes GT; Kjeldsen SE
    Blood Press; 2004; 13(6):330-4. PubMed ID: 15771216
    [No Abstract]   [Full Text] [Related]  

  • 8. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 9. ALLHAT, or the soft science of the secondary end point.
    Neely DB
    Ann Intern Med; 2004 Jul; 141(1):77. PubMed ID: 15238380
    [No Abstract]   [Full Text] [Related]  

  • 10. ALLHAT in perspective: implications to clinical practice and clinical trials.
    Yusoff K
    Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
    Moser M
    J Clin Hypertens (Greenwich); 2003; 5(1):5-8. PubMed ID: 12556646
    [No Abstract]   [Full Text] [Related]  

  • 12. The ALLHAT report: a case of information and misinformation.
    Weber MA
    J Clin Hypertens (Greenwich); 2003; 5(1):9-13. PubMed ID: 12556647
    [No Abstract]   [Full Text] [Related]  

  • 13. ALLHAT: a critical assessment.
    Sjöholm A
    Blood Press; 2004; 13(2):75-9. PubMed ID: 15182109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALLHAT and ANBP2: what have we learned from recent mega-trials?
    Sander GE; Giles TD
    Am J Geriatr Cardiol; 2003; 12(4):267-71. PubMed ID: 12888711
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Whelton PK; Williamson JD; Louis GT; Davis BR; Cutler JA
    Clin Exp Hypertens; 1996; 18(3-4):569-79. PubMed ID: 8743044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting messages but not contradicting results from ALLHAT and ANBP2.
    Hedner T; Himmelmann A; Kjeldsen SE
    Blood Press; 2003; 12(2):68-9. PubMed ID: 12797626
    [No Abstract]   [Full Text] [Related]  

  • 17. The ALLHAT trial: strengths and limitations.
    Fagard RH
    J Hypertens; 2003 Feb; 21(2):229-32. PubMed ID: 12569242
    [No Abstract]   [Full Text] [Related]  

  • 18. ALLHAT and AFFIRM.
    Liebson PR
    Prev Cardiol; 2003; 6(1):54-60. PubMed ID: 12624564
    [No Abstract]   [Full Text] [Related]  

  • 19. The ALLHAT trial: a verdict or a challenge?
    Zanchetti A; Mancia G
    J Hypertens; 2003 Feb; 21(2):223. PubMed ID: 12569240
    [No Abstract]   [Full Text] [Related]  

  • 20. All hats off to ALLHAT: a massive study with clear messages.
    Chalmers J
    J Hypertens; 2003 Feb; 21(2):225-8. PubMed ID: 12569241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.